The policy response to HIV in prisons worldwide. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


The policy response to HIV in prisons worldwide.

Int Conf AIDS. 1992 Jul 19-24;8(1):Mo12 (abstract no. MoD 0039). Unique Identifier : AIDSLINE ICA8/92399997
Hammett T; Harding TW; Egger S; Heilpern H; Abt Associates, Cambridge, MA.

Abstract: OBJECTIVES: This paper compares actual prison policies on HIV disease with WHO's recommendations (1987). METHODS: Data are from surveys for WHO (Harding, 42 nations), US Justice Dept. (Hammett, US and Canada), and the Australian Dept. of Community Services and Health (Egger and Heilpern, Australia). RESULTS: WHO recommendations include up-to-date education and no involuntary HIV testing or segregation of HIV-infected prisoners. Actual policies (as of 1989-90) in the surveyed nations are summarized below. TABULAR DATA, SEE ABSTRACT VOLUME. CONCLUSIONS: Actual policies differ substantially from WHO recommendations. There should be continuing discussion with prison officials worldwide regarding appropriate HIV policies.
Keywords: Comparative Study *Health Policy Human HIV Infections/*PREVENTION & CONTROL Mass Screening Patient Education Patient Isolation *Prisoners World Health World Health Organization ABSTRACTKWDcomparativestudyKWDhealthpolicyhumanhivinfections/KWDprevention&controlmassscreeningpatienteducationpatientisolationKWDprisonersworldhealthworldhealthorganizationabstract
921230
M92C5350

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .